Patients with primary thyroid cancer who received radioactive iodine therapy had elevated risk for melanoma/skin cancer.
Of Interest
Immunotherapy Combination May Demonstrate Benefit in Patients With Cutaneous Melanoma
Presurgical treatment with the novel drug vidutolimod and the PD-1 checkpoint inhibitor nivolumab may improve tumor control in patients with stage III cutaneous melanoma, according to a recent study published by Davar et al in Cancer Cell.
Wide local excision, Mohs remain primary treatment options for positive tumor margins
Positive margins are infrequent following standard excision, but when they do occur it is mostly in the upper extremities.
Quick Chat About Skin Cancer with Yale Dermatologist Sean Christensen
Skin cancer is the most common type of cancer in the United States, with millions of cases diagnosed each year. According to the National Institutes of Health (NIH), basal cell carcinoma and squamous cell carcinoma are the most frequently occurring forms, with over 4 million and 1 million cases annually, respectively.